Production of functionalized single-chain Fv antibody fragments binding to the ED-B domain of the B-isoform of fibronectin in pichia pastoris

Protein Expression and Purification

Volumn 21, Issue 1, 2001, Pages 156-164

  Marty, Cornelia ^a   Scheidegger, Patrick ^b   Ballmer Hofer, Kurt ^b   Klemenz, Roman ^a   Schwendener, Reto A ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANGIOGENESIS; CARBOXY TERMINAL SEQUENCE; CYTOTOXICITY; FIBRONECTIN; HYDROPHILICITY; LIPOSOME; MEMBRANE PROTEIN; RECEPTOR PROTEIN; SINGLE CHAIN FV FRAGMENT; THIOL;

PICHIA PASTORIS;

EID: 0034952304     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.2000.1362     Document Type: Article

References (35)

1. Medical applications of single-chain antibodies
2. Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domain
3. Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon
4. Evidence of ED-B+ fibronectin synthesis in human tissues by non-radioactive RNA in situ hybridization. Investigations on carcinoma (oral squamous cell and breast carcinoma), chronic inflammation (rheumatoid synovitis) and fibromatosis (Morbus Dupuytren)
5. Large-scale procedure for the purification of fibronectin domains
6. Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues
7. Angiogenesis: Mechanistic insights, neovascular diseases, and therapeutic prospects
8. Angiogenesis and angiogenesis inhibition: An overview
9. A high-affinity human antibody that targets tumoral blood vessels
10. High-level secretion of a wheat lipid transfer protein in Pichia pastoris
11. An engineered bivalent single-chain antibody fragment that increases antigen binding activity
12. Recent advances in the expression of foreign genes in Pichia pastoris
13. Radioactive labeling of recombinant antibody fragments by phosphorylation using human casein kinase II and [gamma-32P]-ATP
14. Efficient one-step direct labelling of recombinant antibodies with technetinm-99m
15. Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform
16. One-step preparation of competent Escherichia coli: Transformation and storage of bacterial cells in the same solution
17. A rapid boiling method for the preparation of bacterial plasmids
18. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
19. Reduction and fluorescent labeling of cyst(e)ine-containing proteins for subsequent structural analyses
20. Collagen substrata for studies on cell behavior
21. Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts
22. Single-chain Fv with manifold N-glycans as bifunctional scaffolds for immunomolecules
23. Generation of rabbit monoclonal antibody fragments from a combinatorial phage display library and their production in the yeast Pichia pastoris
24. Disruption of the KEX1 gene in Pichia pastoris allows expression of full-length murine and human endostatin
25. Cloning, expression, and in vitro activity of human endostatin
26. Expression of human interleukin-17 in Pichia pastoris: Purification and characterization
27. High-level expression of human interleukin-17 in the yeast Pichia pastoris
28. Secretory expression and characterization of insulin in Pichia pastoris
29. Liposomes: Opportunities in drug delivery
30. Immunoliposomes bearing polyethyleneglycol -coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo
31. Comparative studies of the preparation of immunoliposomes with the use of two bifunctional coupling agents and investigation of in vitro immunoliposome-target cell binding by cytofluorometry and electron microscopy
32. Sterically stabilized anti-HER2 immunoliposomes: Design and targeting to human breast cancer cells in vitro
33. Preparation of immunoliposomes directed against CD34 antigen as target
34. Source of oncofetal ED-B-containing fibronectin: Implications of production by both tumor and endothelial cells
35. Inhibition of tumor growth by specific targeting of anti-ED-B fibronectin scFv antibody modified liposomes in the F9 mouse teratocarcinoma model